1. Academic Validation
  2. RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNA

RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNA

  • Cell Prolif. 2025 May 13:e70059. doi: 10.1111/cpr.70059.
Hongda An 1 Anliang Xia 2 3 4 Siyuan Liu 2 3 4 Dongjun Luo 1 Longpo Geng 2 3 4 Binghua Li 1 Beicheng Sun 1 2 3 4 Zhu Xu 1 2 3 4
Affiliations

Affiliations

  • 1 Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Graduate School of Peking Union Medical College, Nanjing, China.
  • 2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • 3 MOE Innovation Center for Basic Research in Tumor Immunotherapy, Hefei, China.
  • 4 Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China.
Abstract

Targeting base excision repair (BER) has been an attractive strategy in Cancer therapeutics. RNA-binding motif protein 39 (RBM39) modulates the alternative splicing of numerous genes involved in Cancer occurrence and progression. However, whether and how RBM39 regulates BER in hepatocellular carcinoma (HCC) remain unclear. Here, we found that under oxidative stress, RBM39 degradation or knockdown decreased BER efficiency in HCC cells using a well-designed BER reporter. Further assays showed that RBM39 promoted HCC cell proliferation, migration, and invasion, enhancing cell survival and inhibiting Apoptosis. Mechanistically, RBM39 interacted with the mRNA of the essential Glycosidase 8-oxoguanine-DNA glycosylase 1 (OGG1), thereby stabilising OGG1 mRNA. This in turn increases OGG1 expression and promotes BER efficiency in HCC. Moreover, data suggested that RBM39 degradation, combined with oxidative damage, could be more effective for HCC treatment than monotherapy, both in vitro and in xenograft mice models. Overall, we demonstrated that RBM39 regulated OGG1 stabilisation and improved BER efficiency, suggesting that combining the RBM39 degradant indisulam with the oxidising agent KBrO3 could be an emerging strategy for HCC treatment.

Keywords

OGG1; RBM39; base excision repair; hepatocellular carcinoma; mRNA stability.

Figures
Products